PAUL MANNING

Profile

First Name

: PAUL

Middle Name

:

Last Name

: MANNING

Related Companies
Titles
Company Name
Related People
DIRECTOR
GEN9, INC.
JENNIFER CAMACHO, FRANCO CERRINA, GEORGE CHURCH, NEIL COOK, WALI DAI, WEILI DAI, DREW ENDY, MARTIN GOLDBERG, JAMES HOLLENHORST, JIM HOLLENHORST, JOSEPH JACOBSON, STEPHEN JURVETSON, KEVIN MUNNELLY, STANLEY ROSE, BILL SCALZULLI, SCOTT SCHOEN, LAWRENCE SILVERSTEIN, DAVID STONE, JACOB THAYSEN, JEREMY WERTHEIMER, AARON ZUCKER
DIRECTOR
ENZYMATICS INC
CHRISTOPHER BENOIT, JACK PERCOSKIE, STEPHEN PICONE, IAN RATCLIFFE
DIRECTOR
AVEXIS, INC.
THOMAS DEE, JOHN D. HARKEY, BRIAN KASPAR, ANDREW F. KNUDTEN, BONG KOH, JAMES L-ITALIEN, JONATHAN LEFF, SUKUMAR NAGENDRAN, SEAN NOLAN, CAROLE NUECHTERLAIN
DIRECTOR, EXECUTIVE OFFICER, PROMOTER
VERRICA PHARMACEUTICALS INC.
JOSEPH BONACCORSO, ANTHONY CAVALLO, GAVIN CORCORAN, MATTHEW DAVIDSON, LAWRENCE EICHENFIELD, JOHN KIRBY, PAUL B. MANNING, DIEM NGUYEN, GLENN OCLASSEN, MARK PRYGOCKI, JAMES C. REEBALS, JAYSON RIEGER, NOAH ROSENBERG, SEAN STALFORT, TED WHITE, DAVID ZAWITZ
DIRECTOR
ARCHERDX, INC.
MARVIN CARUTHERS, MARVIN H. CARUTHERS, BENJAMIN CARVER, TODD DRULEY, STEVEN KAFKA, STEVEN J. KAFKA, CHRISTIAN LAPOINTE, KYLE LEFKOFF, KYLE A. LEFKOFF, PAUL B. MANNING, MARK MASSARO, JASON MYERS, JASON W. MYERS, BRITTON A. RUSSELL, JASON C. RYAN, JOSHUA STAHL
DIRECTOR
ADVANTAGENE, INC.
LAURA AGUILAR, ESTUARDO AGUILAR-CORDOVA, EDWARD J. BENZ, MITCHELL FINER, CHRIS MARTELL, GLENN MATTES, UDI MERAV, FRED MERMELSTEIN, STEPHEN C. ROCAMBOLI, ALAN SMITH, SEAN STALFORT
DIRECTOR
TOLERION, INC.
GRAEME CURIE, JOHN DONOVAN, ALEXANDER FLEMING, SCOTT GEYER, RANDOLPH JOHNSON, SEAN STALFORT, LAWRENCE STEINMAN, JAMES STUTZ, STEPHEN ZACHARY
EXECUTIVE OFFICER
BLUE MARLIN THERAPEUTICS, INC.
SEAN STALFORT
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-10-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-06 
2020-03-05
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2019-12-17 
2020-03-05
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2020-02-26 
2020-02-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-28 
2020-01-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-01-16 
2019-12-17
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-12-11 
2019-05-24
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-10 
2018-11-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-13 
2018-03-20
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-05 
2018-02-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-20 
2017-12-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-15 
2015-12-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-02 
2015-09-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-03 
2013-08-15
D
Link
OTHER 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2013-08-01 
2012-05-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-05-18 
2011-09-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-25